Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Postoperative Complications × Thyroxine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 8 Hypothyroidism 5 Thyroid Diseases 1 Recurrence 1 Postoperative Complications 1 Polycystic Ovary Syndrome 1 Neoplasms 1 Infertility, Female 1 Goiter 1 Fatigue 1 Depression 1 Anxiety Disorders 1 Advanced Differentiated Thyroid Gland Carcinoma 1

Interventions

ferric carboxymaltose 3 Ropivacaine 3 Sevoflurane 2 Radiotherapy 2 Propofol 2 Proctectomy 2 Oxaliplatin 2 Immunonutrition Diet 2 Hepatectomy 2 Dexamethasone 2 Counseling 2 Colectomy 2 streptococcal preparation 722 1 ferrous sulfate 1 World Health Organization oral rehydration solution 1 Warm Ischemia 1 Videotape Recording 1 Video-Assisted Surgery 1 Ultrasonography 1 Tranexamic Acid 1 Tracheostomy 1 Tomography, X-Ray Computed 1 Tidal Volume 1 Thyroxine 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Tea 1 Surgical Procedures, Operative 1 Sugammadex 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548715 2022-07-13

LSHT

University of Alberta

Phase 2/3 Withdrawn

Hypothyroidism, Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡